- Home
- CRGX vs SSYS Comparison
CRGX vs SSYS Comparison
Compare CRGX & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- SSYS
- Stock Information
- Founded
- CRGX 2021
- SSYS 1989
- Country
- CRGX United States
- SSYS United States
- Employees
- CRGX N/A
- SSYS N/A
- Industry
- CRGX
- SSYS Computer peripheral equipment
- Sector
- CRGX
- SSYS Technology
- Exchange
- CRGX Nasdaq
- SSYS Nasdaq
- Market Cap
- CRGX 190.0M
- SSYS 857.2M
- IPO Year
- CRGX 2023
- SSYS 1994
- Fundamental
- Price
- CRGX $4.59
- SSYS $11.18
- Analyst Decision
- CRGX Hold
- SSYS Strong Buy
- Analyst Count
- CRGX 7
- SSYS 4
- Target Price
- CRGX $5.33
- SSYS $12.50
- AVG Volume (30 Days)
- CRGX 1.9M
- SSYS 408.1K
- Earning Date
- CRGX 08-11-2025
- SSYS 08-28-2025
- Dividend Yield
- CRGX N/A
- SSYS N/A
- EPS Growth
- CRGX N/A
- SSYS N/A
- EPS
- CRGX N/A
- SSYS N/A
- Revenue
- CRGX N/A
- SSYS $564,454,000.00
- Revenue This Year
- CRGX $57.81
- SSYS $2.01
- Revenue Next Year
- CRGX N/A
- SSYS $4.01
- P/E Ratio
- CRGX N/A
- SSYS N/A
- Revenue Growth
- CRGX N/A
- SSYS N/A
- 52 Week Low
- CRGX $3.00
- SSYS $6.05
- 52 Week High
- CRGX $25.45
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- CRGX 61.56
- SSYS 53.25
- Support Level
- CRGX $4.32
- SSYS $10.63
- Resistance Level
- CRGX $4.63
- SSYS $11.90
- Average True Range (ATR)
- CRGX 0.16
- SSYS 0.34
- MACD
- CRGX 0.04
- SSYS 0.01
- Stochastic Oscillator
- CRGX 76.44
- SSYS 56.89
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.